Search
Now showing items 1-7 of 7
Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study
Fink, Anna Maria et al. (2017)
Wissenschaftlicher Artikel
Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group
Al-Sawaf, Othman et al. (2017)
Wissenschaftlicher Artikel
Impact of telomere length on the outcome of allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukaemia: results from the GCLLSG CLL3X trial
Scheffold, Annika et al. (2017)
Wissenschaftlicher Artikel
Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial
Kraemer, Isabelle et al. (2017)
Wissenschaftlicher Artikel
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes
Xochelli, Aliki et al. (2017)
Wissenschaftlicher Artikel
Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial
Edelmann, J. et al. (2017)
Wissenschaftlicher Artikel
Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group
Hoechstetter, M. A. et al. (2017)
Wissenschaftlicher Artikel